SCHEMBL7524129

SCHEMBL7524129

CCCCCC(C)(C)c1cc(N=Nc2ccc(C(F)(F)F)cc2[N+](=O)[O-])c(O)c(C(C)(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.42
ALDH1A1 P00352 4/20 0.42
MAPK1 P28482 3/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
CNR1 P21554 3/20 0.35
CYP3A4 P08684 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CYP2C19 P33261 1/20 0.34
CES2 O00748 1/20 0.34
ACHE P22303 1/20 0.34
CES1 P23141 1/20 0.34
KCNMA1 Q12791 1/20 0.34
MITF O75030 1/20 0.34
HPGD P15428 1/20 0.34
MC4R P32245 1/20 0.34
CNR2 P34972 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6860826 0.93 MAPT (0.42) MAPTALDH1A1MAPK1KDM4EGAA
SCHEMBL7524124 0.88 MAPT (0.44) MAPTALDH1A1MAPK1KDM4EGAA
SCHEMBL10385274 0.85 GPR35 (0.39) MAPTALDH1A1MAPK1KDM4EGAA
SCHEMBL6865303 0.82 MAPK1 (0.48) MAPTALDH1A1MAPK1KDM4EGAA
SCHEMBL9008430 0.82 CES2 (0.39) CNR1CYP1A2CES2ACHECES1
SCHEMBL5643778 0.82 MEN1 (0.41) MAPTALDH1A1MAPK1CNR1MEN1
SCHEMBL5651093 0.82 CNR1 (0.33) MAPTALDH1A1MAPK1KDM4EGAA
SCHEMBL9177992 0.81 CES2 (0.39) CNR1CYP1A2CES2ACHECES1
SCHEMBL6864578 0.81 MAPT (0.38) MAPTALDH1A1MAPK1KDM4EGAA
SCHEMBL6868079 0.80 MAPT (0.44) MAPTALDH1A1MAPK1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6489383-B1 SUCH AS 2-(2-HYDROXY-3-(1,1-DI(4-2-(BROMOETHOXY)PHENYL) ETHYL)-5-TERT-BUTYLPHENYL)-2H-BENZOTRIAZOLE FOR USE AS STOVING LACQUER, FINISHING ENAMEL FOR AUTOMOBILES CIBA SPECIALTY CHEMICALS CORPORATION 2002-12-03 US disclosed
US-20020169239-A1 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith WOOD MERVIN G (US) 2002-11-14 US disclosed
US-6392056-B1 FOR THERMOPLASTIC RESINS CIBA SPECIALTY CHEMICAL CORPORATION 2002-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169239-A1 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith SUV39H1, SUV39H2, PAH MAPT 287/4885ALDH1A1 85/4885MAPK1 3801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.